LSVT LOUD and LSVT BIG: Behavioral Treatment Programs for Speech and Body Movement in Parkinson Disease

Overview

Journal Parkinsons Dis

Publisher Wiley

Date 2012 Apr 25

PMID 22530161

Citations 50

Authors

Cynthia Fox

Georg Ebersbach

Lorraine Ramig

Shimon Sapir

Affiliations

Soon will be listed here.

Abstract

Recent advances in neuroscience have suggested that exercise-based behavioral treatments may improve function and possibly slow progression of motor symptoms in individuals with Parkinson disease (PD). The LSVT (Lee Silverman Voice Treatment) Programs for individuals with PD have been developed and researched over the past 20 years beginning with a focus on the speech motor system (LSVT LOUD) and more recently have been extended to address limb motor systems (LSVT BIG). The unique aspects of the LSVT Programs include the combination of (a) an exclusive target on increasing amplitude (loudness in the speech motor system; bigger movements in the limb motor system), (b) a focus on sensory recalibration to help patients recognize that movements with increased amplitude are within normal limits, even if they feel "too loud" or "too big," and (c) training self-cueing and attention to action to facilitate long-term maintenance of treatment outcomes. In addition, the intensive mode of delivery is consistent with principles that drive activity-dependent neuroplasticity and motor learning. The purpose of this paper is to provide an integrative discussion of the LSVT Programs including the rationale for their fundamentals, a summary of efficacy data, and a discussion of limitations and future directions for research.

Citing Articles

Exercise, Neuroprotective Exerkines, and Parkinson's Disease: A Narrative Review.

Mitchell A, Bliss R, Church F Biomolecules. 2024; 14(10).

PMID: 39456173 PMC: 11506540. DOI: 10.3390/biom14101241.

The Effectiveness of Lee Silverman Voice Treatment (LSVT LOUD) on Children's Speech and Voice: A Scoping Review.

Papadopoulos A, Voniati L, Ziavra N, Tafiadis D Brain Sci. 2024; 14(9).

PMID: 39335431 PMC: 11429989. DOI: 10.3390/brainsci14090937.

Reimagining Day Rehabilitation For Frailty and Neurodegenerative Conditions through the integrated Rehabilitation and EnAblement Program (iREAP).

Maiden G, Kingsford A, Wang A, Tran-Nam A, Nelson J Int J Integr Care. 2024; 24(3):21.

PMID: 39308759 PMC: 11414462. DOI: 10.5334/ijic.8066.

A Conceptual Framework and Treatment Taxonomy for Respiratory Lung Volume Training (RLVT).

Lowell S, Edwards H, Freedman-Doan A, Mercado M, Pereyra Maldonado L, Thai J J Voice. 2024; .

PMID: 38538410 PMC: 11424777. DOI: 10.1016/j.jvoice.2024.02.024.

Implications of COVID-19 in Parkinson's disease: the purinergic system in a therapeutic-target perspective to diminish neurodegeneration.

Simoes J, Braga G, Eichler S, da Silva G, Bagatini M Purinergic Signal. 2024; 20(5):487-507.

PMID: 38460075 PMC: 11377384. DOI: 10.1007/s11302-024-09998-7.

References

Conner J, Chiba A, Tuszynski M . The basal forebrain cholinergic system is essential for cortical plasticity and functional recovery following brain injury. Neuron. 2005; 46(2):173-9. DOI: 10.1016/j.neuron.2005.03.003. View

Constantinescu G, Theodoros D, Russell T, Ward E, Wilson S, Wootton R . Treating disordered speech and voice in Parkinson's disease online: a randomized controlled non-inferiority trial. Int J Lang Commun Disord. 2011; 46(1):1-16. DOI: 10.3109/13682822.2010.484848. View

Spielman J, Ramig L, Mahler L, Halpern A, Gavin W . Effects of an extended version of the lee silverman voice treatment on voice and speech in Parkinson's disease. Am J Speech Lang Pathol. 2007; 16(2):95-107. DOI: 10.1044/1058-0360(2007/014). View

Kleim J, Jones T, Schallert T . Motor enrichment and the induction of plasticity before or after brain injury. Neurochem Res. 2003; 28(11):1757-69. DOI: 10.1023/a:1026025408742. View

Baumgartner C, Sapir S, Ramig T . Voice quality changes following phonatory-respiratory effort treatment (LSVT) versus respiratory effort treatment for individuals with Parkinson disease. J Voice. 2002; 15(1):105-14. DOI: 10.1016/s0892-1997(01)00010-8. View

Rochester L, Hetherington V, Jones D, Nieuwboer A, Willems A, Kwakkel G . The effect of external rhythmic cues (auditory and visual) on walking during a functional task in homes of people with Parkinson's disease. Arch Phys Med Rehabil. 2005; 86(5):999-1006. DOI: 10.1016/j.apmr.2004.10.040. View

Farley B, Koshland G . Training BIG to move faster: the application of the speed-amplitude relation as a rehabilitation strategy for people with Parkinson's disease. Exp Brain Res. 2005; 167(3):462-7. DOI: 10.1007/s00221-005-0179-7. View

Rubinstein T, Giladi N, Hausdorff J . The power of cueing to circumvent dopamine deficits: a review of physical therapy treatment of gait disturbances in Parkinson's disease. Mov Disord. 2002; 17(6):1148-60. DOI: 10.1002/mds.10259. View

Rusz J, Cmejla R, Ruzickova H, Ruzicka E . Quantitative acoustic measurements for characterization of speech and voice disorders in early untreated Parkinson's disease. J Acoust Soc Am. 2011; 129(1):350-67. DOI: 10.1121/1.3514381. View

10.

Kleim J, Hogg T, VandenBerg P, Cooper N, Bruneau R, Remple M . Cortical synaptogenesis and motor map reorganization occur during late, but not early, phase of motor skill learning. J Neurosci. 2004; 24(3):628-33. PMC: 6729261. DOI: 10.1523/JNEUROSCI.3440-03.2004. View

11.

King L, Horak F . Delaying mobility disability in people with Parkinson disease using a sensorimotor agility exercise program. Phys Ther. 2009; 89(4):384-93. PMC: 2664996. DOI: 10.2522/ptj.20080214. View

12.

Vuckovic M, Li Q, Fisher B, Nacca A, Leahy R, Walsh J . Exercise elevates dopamine D2 receptor in a mouse model of Parkinson's disease: in vivo imaging with [¹⁸F]fallypride. Mov Disord. 2010; 25(16):2777-84. PMC: 3273304. DOI: 10.1002/mds.23407. View

13.

Sapir S, Ramig L, Spielman J, Fox C . Formant centralization ratio: a proposal for a new acoustic measure of dysarthric speech. J Speech Lang Hear Res. 2009; 53(1):114-25. PMC: 2821466. DOI: 10.1044/1092-4388(2009/08-0184). View

14.

Spielman J, Borod J, Ramig L . The effects of intensive voice treatment on facial expressiveness in Parkinson disease: preliminary data. Cogn Behav Neurol. 2003; 16(3):177-88. DOI: 10.1097/00146965-200309000-00005. View

15.

Jobst E, Melnick M, Byl N, Dowling G, Aminoff M . Sensory perception in Parkinson disease. Arch Neurol. 1997; 54(4):450-4. DOI: 10.1001/archneur.1997.00550160080020. View

16.

Keus S, Munneke M, Nijkrake M, Kwakkel G, Bloem B . Physical therapy in Parkinson's disease: evolution and future challenges. Mov Disord. 2008; 24(1):1-14. DOI: 10.1002/mds.22141. View

17.

Marchese R, Diverio M, Zucchi F, Lentino C, Abbruzzese G . The role of sensory cues in the rehabilitation of parkinsonian patients: a comparison of two physical therapy protocols. Mov Disord. 2000; 15(5):879-83. DOI: 10.1002/1531-8257(200009)15:5<879::aid-mds1018>3.0.co;2-9. View

18.

Jobges E, Spittler-Schneiders H, Renner C, Hummelsheim H . Clinical relevance of rehabilitation programs for patients with idiopathic Parkinson syndrome. II: Symptom-specific therapeutic approaches. Parkinsonism Relat Disord. 2006; 13(4):203-13. DOI: 10.1016/j.parkreldis.2006.07.018. View

19.

McClean M, Tasko S . Association of orofacial with laryngeal and respiratory motor output during speech. Exp Brain Res. 2002; 146(4):481-9. DOI: 10.1007/s00221-002-1187-5. View

20.

Constantinescu G, Theodoros D, Russell T, Ward E, Wilson S, Wootton R . Home-based speech treatment for Parkinson's disease delivered remotely: a case report. J Telemed Telecare. 2009; 16(2):100-4. DOI: 10.1258/jtt.2009.090306. View